Progress in the study of the effect of GLP-1 and its analogues on osteoporosis

Yiran WANG,Xiao ZHAI,Qijin WANG

DOI: https://doi.org/10.3969/j.issn.1006-7108.2015.06.027

2015-01-01

Abstract:Osteoporosis is one of the complications of diabetes.There is a need to prevent and cure osteoporosis when reducing blood glucose.Recently, some researches show that glucagon like peptide 1 ( GLP-1) not only reduces blood sugar level, but also affects the process of bone turnover.GLP-1 and its analogues can relieve the high blood glucose status, resulting in the inhibition of bone resorption.They can influence RANKL signaling pathway to prevent the maturation of osteoclasts.They can also regulate Wnt signaling pathway to influence osteoblast differentiation and maturation.GLP-1and its analogues regulate differentiation of BMSC to osteoblasts instead of adipocytes.They reduce the production of AGEs in the bone, and inhibit the proliferation and differentiation of osteoclasts, resulting in preventing bone metabolism and slowing down the progression of osteoporosis.